TY - BOOK AU - Institute of Medicine A2 - Richard A. Rettig A2 - Adam Yarmolinsky TI - Federal Regulation of Methadone Treatment SN - 978-0-309-05240-5 DO - 10.17226/4899 PY - 1995 UR - https://nap.nationalacademies.org/catalog/4899/federal-regulation-of-methadone-treatment PB - The National Academies Press CY - Washington, DC LA - English KW - Health and Medicine AB - For nearly three decades, methadone hydrochloride has been the primary means of treating opiate addiction. Today, about 115,000 people receive such treatment, and thousands more have benefited from it in the past. Even though methadone's effectiveness has been well established, its use remains controversial, a fact reflected by the extensive regulation of its manufacturing, labeling, distribution, and use. The Food and Drug Administration regulates the safety and effectiveness of methadone, as it does for all drugs, and the Drug Enforcement Administration regulates it as a controlled substance. However, methadone is also subjected to a unique additional tier of regulation that prescribes how and under what circumstances it may be used to treat opiate addiction. Federal Regulation of Methadone Treatment examines current Department of Health and Human Services standards for narcotic addiction treatment and the regulation of methadone treatment programs pursuant to those standards. The book includes an evaluation of the effect of federal regulations on the provision of methadone treatment services and an exploration of options for modifying the regulations to allow optimal clinical practice. The volume also includes an assessment of alternatives to the existing regulations. ER -